Contraception in adolescents with obesity and diabetes mellitus
| Autor: | M. R. Shaydullina, F. V. Valeeva, A. F. Soubchankoulova, P. A. Khusieva |
|---|---|
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | Problems of Endocrinology. 68:137-145 |
| ISSN: | 2308-1430 0375-9660 |
| DOI: | 10.14341/probl12760 |
| Popis: | Today most adolescents have their first sexual experience at the age of 15–19. However, only 44% of girls and young women (15–24 years old) report about contraception at that moment. A decision on pregnancy in adolescence is a difficult choice and any scenario may cause serious medical and social problems. Complications after an artificial abortion have a negative impact on a woman’s fertility. Diabetes mellitus type 1 and arterial hypertension accompanied with obesity within the metabolic syndrome are defined by the World Health Organization (WHO) as diseases, which increase risk of an unplanned pregnancy. The article consoders problems of interaction of a doctor and a teenage girl with endocrinopathy, when discussing her sexual health, the analysis of the literature reflecting the influence of contraception on the course of the underlying pathology is presented. The authors formed a list of drugs acceptable for use in diabetes and obesity based on assessment of risks and preferences from the use of different methods of fertility control. The work contains information about the procedure of starting contraception, the rules of future dynamic monitoring of the patient. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|